Nordson : First Quarter 2025 Results Presentation

Investor Presentation

April 15, 2025

Nasdaq: NDSN

NBS NEXT

OWNER MINDSET

WINNING TEAMS

Nordson is a growth compounder with unique competitive advantages

Company Founded	2024 Revenue	2024 EBITDA%	Employees	Countries with
								Direct Presence
1954		$2.7B	32%		8,000+		35+

3

By the Numbers

Consistent Record	Demonstrated	Disciplined focus	Solid Returns	Differentiated
Value to
of Growth	on profitability	Product Portfolio*
Customers

6%	55%	30%	13%	2,100+
Sales Growth	Gross Margins	EBITDA Margins	ROIC	Global Patents
				Held

4

Consistent value to

shareholders

61 yrs.

of Annual

Dividend

Increases

Note: Financial amounts presented are averages of 2019 - 2024, except ROIC, which is 2024, and dividends which updated August 2024

*Active Patents as of 10/31/24

Diversified Sources of Sales

FY2024 Profile - $2.7 Billion

Product Type

42%			Parts and
		Consumables
	58%		Systems

High percentage of recurring

sales from parts and

consumables.

Geographies

29%

44%		Americas
	Europe

Asia Pacific

27%

Diversified geographic footprint.

Direct presence in over

35 countries.

5

Diversified End Markets

Medical	Electronics	Consumer Non-Durable	Industrial
27% of revenue	25% of revenue	21% of revenue	14% of revenue

Remaining Markets

13% of revenue

• Balloons, extrusions, delivery catheters and other minimally invasive devices
• Single-usefittings, connectors, fluid transfer components in medical equipment and surgical procedures
• Single-usespecialty cannula for cardio-pulmonary procedures

6

	Semiconductor packaging		Box sealing		Construction and industrial
	Wafer-level packaging		Baby diapers		machinery
	Rigid container
	Printed circuit boards		Convenience food packaging
	Aerospace
	Electronic component		Beverage straw and spot
	Chemical
	assembly - mobile phone,		attachment	
	camera, ear buds, PC		Container and bottle labeling		Defense
	Automotive electronics
			Energy

• Consumer durable
• Automotive
• Animal health and delivery systems

2024 revenue mix includes Atrion acquisition. Data is for directional use only.

How We Are Organized

INDUSTRIAL PRECISION SOLUTIONS		MEDICAL FLUID SOLUTIONS		ADVANCED TECHNOLOGY SOLUTIONS
Adhesives, Industrial Coatings,	Interventional Solutions, Fluid Components	Electronic Processing Systems
Measurement and Control Solutions & Polymer Processing Systems	& Engineered Fluid Dispensing		& Test and Inspection
55%			26%		19%
REVENUE		REVENUE		REVENUE

7	Segment average mix for the full fiscal year ended 10/31/24

Industrial Precision Solutions (IPS)

What we do: Product lines reduce material consumption, increase line efficiency, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This business primarily serves the industrial, consumer durables and non-durables markets.

Fiscal 2024 Revenue	Fiscal 2024 EBITDA
$1.4M	37%

Strategic Focus

• New applications for secular trends, including electric vehicle battery, advanced packaging, automotive electronics and solar

Geographic Diversification

Historical 5 Yr. Sales CAGR

			6%	$1,399
		$1,123
24%
40%	Americas
	Europe
36%		Asia
		2019**		2024

8

• Material, machinery and process innovations
• Leverage aftermarket opportunity with the large systems installed base

**2019 revenue number excludes Xaloy screws and barrels business.

IPS End Markets

% of Revenue / Applications / Growth Rates

	CONSUMER NONDURABLE			INDUSTRIAL			OTHER
	40% of IPS Sales			35% of IPS Sales			25% of IPS Sales
	Corrugated and carton packaging			Industrial manufacturing machinery			Consumer durable (appliance / wood)
	Food and beverage packaging		 Plastic processing and recycling			Agricultural
	Disposable hygiene			Metallic container and can coating			Automotive
	Disposable medical garments			Building and construction		 Solar and electric battery
	Market Growth Rate			Market Growth Rate			Market Growth Rate
	1-3%			1-3%			2-4%

9

Medical Fluid Solutions (MFS)

What we do: Fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips, and fluid connection components are used to dispense or control fluids within customers' medical devices or products, as well as production processes.

Fiscal 2024 Revenue		Fiscal 2024 EBITDA	Strategic Focus
$696M			37%	 Differentiated single-use component
				solutions and devices:
				•	Surgical solutions, including
		Historical 5 Yr. Sales CAGR		minimally invasive
Geographic Diversification		(including 2024 Atrion acquisition)*	•	Medical fluid management
			$846		components
			•	Medical device manufacturing
14%	Americas		8%
	$574		•	Industrial technologies
	Europe
18%
Asia			 Driving growth through differentiated
68%
			products in defined market niches
				 Scaling through M&A, both platform
		2019	2024*	and technology tuck-in

10

*2024 includes Atrion acquisition contribution